Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - OPERATING INCOME
Operating Income IOVA - Iovance Biotherapeutics, Inc.
-461 M
LAST VALUE
-15.93%
2 YEAR CAGR
-29.13%
5 YEAR CAGR
-35.16%
10 YEAR CAGR